{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:38:23Z","timestamp":1792643903528,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10072-016-2556-3","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T12:03:49Z","timestamp":1459512229000},"page":"717-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients"],"prefix":"10.1007","volume":"37","author":[{"given":"David","family":"Cioncoloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ginanneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Carone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boni","family":"Veronica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"2556_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S0140-6736(75)92779-8","volume":"2","author":"A Aharonov","year":"1975","unstructured":"Aharonov A, Abramsky O, Tarrab-Hazdai R, Fuchs S (1975) Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet 2:340\u2013342","journal-title":"Lancet"},{"key":"2556_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1196\/annals.1254.056","volume":"998","author":"RJ Barohn","year":"2003","unstructured":"Barohn RJ (2003) Standards of measurements in myasthenia gravis. Ann N Y Acad Sci 998:432\u2013439","journal-title":"Ann N Y Acad Sci"},{"key":"2556_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","volume":"48\u201349","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun 48\u201349:143\u2013148","journal-title":"J Autoimmun"},{"key":"2556_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/mus.23245","volume":"46","author":"TM Burns","year":"2012","unstructured":"Burns TM, Graham CD, Rose MR, Simmons Z (2012) Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle Nerve 46:9\u201325","journal-title":"Muscle Nerve"},{"key":"2556_CR5","first-page":"218","volume":"42","author":"GA Fregonezi","year":"2006","unstructured":"Fregonezi GA, Regiane-Resqueti V, Pradas J, Vigil L, Casan P (2006) The relationship between lung function and health-related quality of life in patients with generalized myasthenia gravis. Arch Bronconeumol 42:218\u2013224","journal-title":"Arch Bronconeumol"},{"key":"2556_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/mus.10489","volume":"29","author":"JM Gilchrist","year":"2004","unstructured":"Gilchrist JM, Sachs GM (2004) Electrodiagnostic studies in the management and prognosis of neuromuscular disorders. Muscle Nerve 29:165\u2013190","journal-title":"Muscle Nerve"},{"key":"2556_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jama.1994.03520080061045","volume":"272","author":"TM Gill","year":"1994","unstructured":"Gill TM, Feinstein AR (1994) A critical appraisal of the quality of quality-of-life measurements. JAMA 272:619\u2013626","journal-title":"JAMA"},{"key":"2556_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","volume":"118","author":"GH Guyatt","year":"1993","unstructured":"Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118:622\u2013629","journal-title":"Ann Intern Med"},{"key":"2556_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/mus.10378","volume":"27","author":"I Heliopoulos","year":"2003","unstructured":"Heliopoulos I, Patlakas G, Vadikolias K, Artemis N, Kleopa KA, Maltezos E, Piperidou H (2003) Maximal voluntary ventilation in myasthenia gravis. Muscle Nerve 27:715\u2013719","journal-title":"Muscle Nerve"},{"key":"2556_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ana.22312","volume":"69","author":"O Higuchi","year":"2011","unstructured":"Higuchi O, Hamuro J, Motomura M, Yamanashi Y (2011) Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69:418\u2013422","journal-title":"Ann Neurol"},{"key":"2556_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365\u2013368","journal-title":"Nat Med"},{"key":"2556_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/WNF.0b013e31823c5480","volume":"35","author":"S Ito","year":"2012","unstructured":"Ito S, Masuda M, Tanaka S, Takagi M, Tanaka C, Yamada N, Nakajima K, Akashi T, Hirano T, Utsumi H (2012) Low-dose glucocorticoid therapy complements the pituitary-adrenocortical system and reduces anxiety and insomnia in myasthenia gravis patients. Clin Neuropharmacol 35:30\u201336","journal-title":"Clin Neuropharmacol"},{"key":"2556_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki III","year":"2000","unstructured":"Jaretzki A III, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"2556_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1172-2-44","volume":"2","author":"VC Juel","year":"2007","unstructured":"Juel VC, Massey JM (2007) Myasthenia gravis. Orphanet J Rare Dis 2:44","journal-title":"Orphanet J Rare Dis"},{"key":"2556_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10072-014-1659-y","volume":"35","author":"J Kalita","year":"2014","unstructured":"Kalita J, Kohat AK, Misra UK (2014) Predictors of outcome of myasthenic crisis. Neurol Sci 35:1109\u20131114","journal-title":"Neurol Sci"},{"key":"2556_CR16","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1183\/09031936.95.08071130","volume":"8","author":"SP Keenan","year":"1995","unstructured":"Keenan SP, Alexander D, Road JD, Ryan CF, Oger J, Wilcox PG (1995) Ventilatory muscle strength and endurance in myasthenia gravis. Eur Respir J 8:1130\u20131135","journal-title":"Eur Respir J"},{"key":"2556_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10072-010-0285-6","volume":"31","author":"K Kulkantrakorn","year":"2010","unstructured":"Kulkantrakorn K, Sawanyawisuth K, Tiamkao S (2010) Factors correlating quality of life in patients with myasthenia gravis. Neurol Sci 31:571\u2013573","journal-title":"Neurol Sci"},{"key":"2556_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/joor.12115","volume":"41","author":"IC Lee","year":"2014","unstructured":"Lee IC, Yang YH, Ho PS, Lee IC (2014) Chewing ability, nutritional status and quality of life. J Oral Rehabil 41:79\u201386","journal-title":"J Oral Rehabil"},{"key":"2556_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00415-009-5279-z","volume":"257","author":"M Leonardi","year":"2010","unstructured":"Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol 257:98\u2013102","journal-title":"J Neurol"},{"key":"2556_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1055\/s-2008-1062260","volume":"28","author":"B Mahadeva","year":"2008","unstructured":"Mahadeva B, Phillips LH, Juel VC (2008) Autoimmune disorders of neuromuscular transmission. Semin Neurol 28:212\u2013227","journal-title":"Semin Neurol"},{"key":"2556_CR21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1468-1331.2010.03017.x","volume":"17","author":"ZF Mao","year":"2010","unstructured":"Mao ZF, Mo XA, Qin C, Lai YR, Olde Hartman TC (2010) Course and prognosis of myasthenia gravis: a systematic review. Eur J Neurol 17:913\u2013921","journal-title":"Eur J Neurol"},{"key":"2556_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/mus.23296","volume":"46","author":"EH Martinez-Lapiscina","year":"2012","unstructured":"Martinez-Lapiscina EH, Erro ME, Ayuso T, Jerico I (2012) Myasthenia gravis: sleep quality, quality of life, and disease severity. Muscle Nerve 46:174\u2013180","journal-title":"Muscle Nerve"},{"key":"2556_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8:475\u2013490","journal-title":"Lancet Neurol"},{"key":"2556_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1749-6632.2012.06817.x","volume":"1274","author":"S Muppidi","year":"2012","unstructured":"Muppidi S (2012) The myasthenia gravis\u2013specific activities of daily living profile. Ann N Y Acad Sci 1274:114\u2013119","journal-title":"Ann N Y Acad Sci"},{"key":"2556_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s100720200027","volume":"23","author":"L Padua","year":"2002","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, Batocchi AP, Punzi C, Mazza S, Padua R, Tonali P (2002) Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire. Neurol Sci 23:59\u201368","journal-title":"Neurol Sci"},{"key":"2556_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s100720100066","volume":"22","author":"L Padua","year":"2001","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R, Tonali P (2001) Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 22:363\u2013369","journal-title":"Neurol Sci"},{"key":"2556_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10072-004-0366-5","volume":"25","author":"L Padua","year":"2005","unstructured":"Padua L, Galassi G, Ariatti A, Aprile I, Caliandro P, Evoli A, Pazzaglia C, Tonali P (2005) Myasthenia gravis self-administered questionnaire: development of regional domains. Neurol Sci 25:331\u2013336","journal-title":"Neurol Sci"},{"key":"2556_CR28","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/1097-4598(200009)23:9<1402::AID-MUS11>3.0.CO;2-B","volume":"23","author":"RH Paul","year":"2000","unstructured":"Paul RH, Cohen RA, Goldstein JM, Gilchrist JM (2000) Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve 23:1402\u20131406","journal-title":"Muscle Nerve"},{"key":"2556_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","volume":"259","author":"A Pevzner","year":"2012","unstructured":"Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kroger S (2012) Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol 259:427\u2013435","journal-title":"J Neurol"},{"key":"2556_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10072-009-0167-y","volume":"31","author":"A Raggi","year":"2010","unstructured":"Raggi A, Leonardi M, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis. Neurol Sci 31:41\u201345","journal-title":"Neurol Sci"},{"key":"2556_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.nmd.2007.01.001","volume":"17","author":"B Rassler","year":"2007","unstructured":"Rassler B, Hallebach G, Kalischewski P, Baumann I, Schauer J, Spengler CM (2007) The effect of respiratory muscle endurance training in patients with myasthenia gravis. Neuromuscul Disord 17:385\u2013391","journal-title":"Neuromuscul Disord"},{"key":"2556_CR32","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.clinph.2005.05.017","volume":"116","author":"A Rostedt","year":"2005","unstructured":"Rostedt A, Padua L, Stalberg EV (2005) Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in myasthenia gravis patients. Clin Neurophysiol 116:2058\u20132064","journal-title":"Clin Neurophysiol"},{"key":"2556_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1468-1331.2006.01149.x","volume":"13","author":"A Rostedt","year":"2006","unstructured":"Rostedt A, Padua L, Stalberg EV (2006) Correlation between regional myasthenic weakness and mental aspects of quality of life. Eur J Neurol 13:191\u2013193","journal-title":"Eur J Neurol"},{"key":"2556_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10072-006-0606-y","volume":"27","author":"A Rostedt","year":"2006","unstructured":"Rostedt A, Padua L, Stalberg EV (2006) Validation of the Swedish version of the disease-specific myasthenia gravis questionnaire. Neurol Sci 27:91\u201396","journal-title":"Neurol Sci"},{"key":"2556_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1034\/j.1600-0722.2001.00030.x","volume":"109","author":"A van der Bilt","year":"2001","unstructured":"van der Bilt A, Weijnen FG, Bosman F, van der Glas HW, Kuks JB (2001) Controlled study of EMG activity of the jaw closers and openers during mastication in patients with myasthenia gravis. Eur J Oral Sci 109:160\u2013164","journal-title":"Eur J Oral Sci"},{"key":"2556_CR36","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ (1999) Myasthenia gravis activities of daily living profile. Neurology 52:1487\u20131489","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-016-2556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-016-2556-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-016-2556-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-016-2556-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:55:00Z","timestamp":1744174500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-016-2556-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2556"],"URL":"https:\/\/doi.org\/10.1007\/s10072-016-2556-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]},"assertion":[{"value":"24 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This manuscript has not been published before and is not being considered for publication elsewhere. I exclude any financial or other relationships that might lead to a conflict of interest. The authors and any research foundation with which they are affiliated did not receive any financial payments or other benefits from any commercial entity related to the subjects of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}